Eris Lifesciences Ltd (BOM:540596)
₹ 1353.8 11.3 (0.84%) Market Cap: 184.29 Bil Enterprise Value: 213.23 Bil PE Ratio: 52.93 PB Ratio: 6.65 GF Score: 93/100

Q4 2020 Eris Lifesciences Ltd Earnings Call Transcript

Jun 02, 2020 / 11:30AM GMT
Release Date Price: ₹519.7 (-1.61%)
Operator

Ladies and gentlemen, good day, and welcome to Eris Lifesciences Q4 and Full Year FY '20 Results Conference Call.

This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Amit Bakshi, Chairman and Managing Director of the company. Thank you, and over to you, sir.

Amit Indubhushan Bakshi
Eris Lifesciences Limited - Chairman & MD

Thank you. Hello, everybody. I hope all of you are keeping well, you're keeping safe. Since most of you are from Bombay, I hope everything is okay from the health part. This is the first call, which we're making in the current COVID era as we call it. Let me just start at the company level, how we have -- how have we handled the situation.

So after

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot